Aura Biosciences Inc
AURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$806.8M
Close$
$0.70
91.4% downside
Current Fair Value
91.4% downsideOvervalued by 91.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $806.80 Million |
|---|---|
| Enterprise Value | $755.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.76 |
| Beta | 0.4 |
| Outstanding Shares | 94,863,400 |
Return
| Return on Equity | -41.56% |
|---|---|
| Return on Assets | -37.63% |
| Return on Invested Capital | -0.34% |
Valuation & Multiples
| P/E Ratio | -4.38 |
|---|---|
| PEG | -6.36 |
| Price to Sales | - |
| Price to Book Ratio | 2.72 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -683.77 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 10.1429▲ 1014.29% |
|---|---|
| Total Calls | 14,700▲ Infinity% |
| Total Puts | 149,100▼ 55.93% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 141.67%▲ 57.35% |
|---|---|
| Total Invested | $678.46M▲ 99.34% |
| Investors Holding | 149▲ 22.00% |
ESG Score
No data